4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000021
Chief Medical Officer acquired 6,349 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-03-12 | Option exercise | +6,349 | $1.08 | $6,857 | 170,869 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-03-12 | Option exercise · Stock Option | −6,349 | 115,880 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1741900533.xml…